FDA grants orphan drug designation to Savara Pharma inhaled antibiotic therapy
The antibiotic, AeroVanc, is a proprietary inhaled dry powder form of vancomycin in a capsule-based device designed for convenient self-administration. In Phase I studies, AeroVanc was well tolerated
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.